Efficacy and Safety of Sorafenib or Lenvatinib for Advanced Hepatocellular Carcinoma after Failure of First-Line Atezolizumab Plus Bevacizumab: A Systematic Review and Meta-Analysis.
Saved in:
| Title: | Efficacy and Safety of Sorafenib or Lenvatinib for Advanced Hepatocellular Carcinoma after Failure of First-Line Atezolizumab Plus Bevacizumab: A Systematic Review and Meta-Analysis. |
|---|---|
| Authors: | Peng, Tzu-Rong1 (AUTHOR) tzu.rong@tzuchi.com.tw, Weng, Yi-Fang1 (AUTHOR) u108534011@gap.kmu.edu.tw, Wu, Ta-Wei1 (AUTHOR) tawei@tzuchi.com.tw, Wu, Chao-Chuan2,3 (AUTHOR) ngchiukwan@yahoo.com.tw, Chou, Yi-Chun3,4 (AUTHOR), Hsu, Ching-Sheng4,5,6 (AUTHOR) hsu.chingsheng@gmail.com |
| Source: | Cancers. Aug2024, Vol. 16 Issue 16, p2813. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20726694 |
|---|---|
| DOI: | 10.3390/cancers16162813 |
